Page 1 | Search Results | Blood | American Society of Hematology

1-11 of 11

Sort by

Sort Order Select

Journal Articles

“FLAG” Regimen Induces Deep, Although Short-Term, Responses in Patients Resistant to Tyrosine Kinases Inhibitors in BP CML.

Ekaterina Romanova, MD, Larisa Girshova, MD, Nadia Siordia, MD, Elena Goriunova, MD, Dmitry Motorin, MD PhD, Elza Lomaia, MD PhD, Marina Konopleva, MD PhD

Blood (2014) 124 (21): 5534.

https://doi.org/10.1182/blood.V124.21.5534.5534

Published: 2014

Journal Articles

Efficacy Of Different Therapeutic Approaches In Blastic Phase Of Chronic Myeloid Leukemia: Single Centre Experience

Elza Lomaia, MD, PhD, Ekaterina Romanova, MD, Larisa Girshova, MD, Yulia Alexeeva, MD, PhD, Eugenia Sbityakova, MD, Elena Goriunova, MD, Vladimir Strugov, MD, Natalia Lazorko, MD, Nadia Siordia, MD, Diana Mescheryakova, MD, Tatiana Silina, MD, Dmitry Motorin, MD, PhD, Andrey Zaritskey, MD, PhD

Blood (2013) 122 (21): 5173.

https://doi.org/10.1182/blood.V122.21.5173.5173

Published: 2013

Journal Articles

High WT1 Expression in 2nd CR of AML Is Predictive for Early Relapse (prospective study)

Larisa Girshova, Ekaterina Romanova, Irina Kholopova, Tatiana Nikulina, Julia Mirolubova, Elena Gorunova, Dmitry Motorin, Andrey Zaritskey

Blood (2012) 120 (21): 4812.

https://doi.org/10.1182/blood.V120.21.4812.4812

Published: 2012

Journal Articles

Normal Blood and Bone Marrow Wt1 Expression Level in Extramedullary Relapse in AML Patient

Larisa Girshova, Ekaterina Romanova, Elena Gorunova, Irina Kholopova, Tatiana Nikulina, Julia Mirolubova, Vladimir Ivanov, Andrey Zaritskey

Blood (2012) 120 (21): 4825.

https://doi.org/10.1182/blood.V120.21.4825.4825

Published: 2012

Journal Articles

Isolated Myeloid Sarcoma Involving the Breast

Larisa Girshova, Ekaterina Romanova, Irina Kholopova, Tatiana Nikulina, Julia Mirolubova, Andrey Zaritskey

Blood (2012) 120 (21): 4345.

https://doi.org/10.1182/blood.V120.21.4345.4345

Published: 2012

Journal Articles

Crude and Age-Adjusted Ph+/Bcr-Abl+ Chronic Myeloid Leukemia Incidence Rate in St. Petersburg and Leningrad Region Between 2006–2011

Kudrat Abdulkadyrov, Elza Lomaia, Natalia Lazorko, Vasiliy Shuvaev, Alla Abdulkadyrova, Irina Martinkevich, Elena Usacheva, Vera Udalieva, Irina Zotova, Elena Machulaitene, Natalia Ilina, Elena Karyagina, Irina Kholopova, Ekaterina Romanova, Eugenia Sbityakova, Tatiana Shneider, Andrey Zaritskey

Blood (2012) 120 (21): 4432.

https://doi.org/10.1182/blood.V120.21.4432.4432

Published: 2012

Journal Articles

Busulfan Exposure Decrease CCyR Rate On Imatinib Therapy - Impact On Recent Pretreatment

Blood (2011) 118 (21): 4452.

https://doi.org/10.1182/blood.V118.21.4452.4452

Published: 2011

Journal Articles

Therapy of Refractory AML with Del(5q) with Low-Dose Lenalidomide

Dmitry Motorin, Elena Goryunova, Ekaterina Romanova, Larisa Girshova, Yulia Alexeeva, Tatiana Nikulina, Andrey Zaritskey

Blood (2011) 118 (21): 4286.

https://doi.org/10.1182/blood.V118.21.4286.4286

Published: 2011

Journal Articles

Only Time Before the Beginning of Treatment and Time to Achieve CCyR Influence the Stability of CCyR In CML-CP Patients On Imatinib Therapy.

Blood (2010) 116 (21): 4476.

https://doi.org/10.1182/blood.V116.21.4476.4476

Published: 2010

Journal Articles

6 Year Experience of Treatment by Imatinib in CML CP Patientsin 6 Million Population Region of Russia(Saint-Petersburg and Leningrad region)with Impact On Time and Kind of Pretreatment.

Kudrat Abdulkadirov, Elza Lomaia, Vasiliy Shuvaev, Alla Abdulkadirova, Vera Udalieva, Elena Usacheva, Elena Machulaitene, Irina Zotova, Ekaterina Poznyak, Elena Koryagina, Natalia Ilina, Tatiana Shneider, Svetlana Stepanova, Ekaterina Romanova, Eugenia Salamatova, Elena Goryunova, Natalija Lazorko, Irina Martinkevich, Andrey Zaritskey

Blood (2009) 114 (22): 4278.

https://doi.org/10.1182/blood.V114.22.4278.4278

Published: 2009

Journal Articles

Experience in Second Line TKI Treatment in 6 Million Region of Russia (St-Petersburg and Leningrad region).

Kudrat Abdulkadirov, Elza Lomaia, Alla Abdulkadirova, Vasiliy Shuvaev, Vera Udalieva, Elena Usacheva, Elena Machulaitene, Irina Zotova, Ekaterina Poznyak, Elena Koryagina, Natalia Ilina, Tatiana Shneider, Svetlana Stepanova, Ekaterina Romanova, Eugenia Salamatova, Elena Goryunova, Natalija Lazorko, Irina Martinkevich, Andrey Zaritskey

Blood (2009) 114 (22): 4288.

https://doi.org/10.1182/blood.V114.22.4288.4288

Published: 2009

NARROW

“FLAG” Regimen Induces Deep, Although Short-Term, Responses in Patients Resistant to Tyrosine Kinases Inhibitors in BP CML.

Efficacy Of Different Therapeutic Approaches In Blastic Phase Of Chronic Myeloid Leukemia: Single Centre Experience

High WT1 Expression in 2nd CR of AML Is Predictive for Early Relapse (prospective study)

Normal Blood and Bone Marrow Wt1 Expression Level in Extramedullary Relapse in AML Patient

Isolated Myeloid Sarcoma Involving the Breast

Crude and Age-Adjusted Ph+/Bcr-Abl+ Chronic Myeloid Leukemia Incidence Rate in St. Petersburg and Leningrad Region Between 2006–2011

Busulfan Exposure Decrease CCyR Rate On Imatinib Therapy - Impact On Recent Pretreatment

Therapy of Refractory AML with Del(5q) with Low-Dose Lenalidomide

Only Time Before the Beginning of Treatment and Time to Achieve CCyR Influence the Stability of CCyR In CML-CP Patients On Imatinib Therapy.

6 Year Experience of Treatment by Imatinib in CML CP Patientsin 6 Million Population Region of Russia(Saint-Petersburg and Leningrad region)with Impact On Time and Kind of Pretreatment.

Experience in Second Line TKI Treatment in 6 Million Region of Russia (St-Petersburg and Leningrad region).

Email alerts

ASH Publications

American Society of Hematology

Email alerts

ASH Publications

American Society of Hematology

This Feature Is Available To Subscribers Only